The Valley Desk

NCT05071209 · Interventional trial

Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Recurrent Alveolar Rhabdomyosarcoma, Recurrent Ewing Sarcoma, Recurrent Lymphoma, Recurrent Malignant Solid Neoplasm, Refractory Alveolar Rhabdomyosarcoma, Refractory Ewing Sarcoma, Refractory Lymphoma, Refractory Malignant Solid Neoplasm

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov